Triple Negative Breast Cancer (TNBC)

Also known as: Triple Negative Breast Cancer / Triple-negative breast cancer / Triple Negative Breast Neoplasms

DrugDrug NameDrug Description
DrugDrug NameTargetType
DrugDrug NamePhaseStatusCount
DB09037Pembrolizumab0Not Yet Recruiting1
DB11595Atezolizumab1Recruiting3
DB06168Canakinumab1Recruiting1
DB00002Cetuximab1Completed1
DB00515Cisplatin1Completed1
DB11714Durvalumab1Not Yet Recruiting1
DB08871Eribulin1Recruiting1
DB00530Erlotinib1Completed1
DB01590Everolimus1Recruiting2
DB01099Flucytosine1Recruiting1
DB11896Gedatolisib1Not Yet Recruiting1
DB00762Irinotecan1Completed2
DB12154Itacitinib1Recruiting1
DB12085LCL-1611Recruiting1
DB09074Olaparib1Active Not Recruiting1
DB01229Paclitaxel1Active Not Recruiting1
DB06603Panobinostat1Recruiting1
DB09037Pembrolizumab1Recruiting3
DB00299Penciclovir1Recruiting1
DB11857Seribantumab1Completed1
DB06287Temsirolimus1Completed1
DB08911Trametinib1Recruiting1
DB11925Vistusertib1Recruiting1
DB11595Atezolizumab1 / 2Terminated1
DB11945Avelumab1 / 2Not Yet Recruiting1
DB00112Bevacizumab1 / 2Not Yet Recruiting1
DB01128Bicalutamide1 / 2Recruiting1
DB01101Capecitabine1 / 2Not Yet Recruiting1
DB01101Capecitabine1 / 2Recruiting1
DB12033Cediranib1 / 2Recruiting1
DB00515Cisplatin1 / 2Not Yet Recruiting1
DB00515Cisplatin1 / 2Terminated1
DB00531Cyclophosphamide1 / 2Not Yet Recruiting1
DB12021Dinaciclib1 / 2Recruiting1
DB11714Durvalumab1 / 2Recruiting1
DB00544Fluorouracil1 / 2Not Yet Recruiting1
DB00650Leucovorin1 / 2Not Yet Recruiting1
DB11793Niraparib1 / 2Recruiting1
DB09035Nivolumab1 / 2Recruiting1
DB09074Olaparib1 / 2Recruiting1
DB09539Omega-3-acid ethyl esters1 / 2Not Yet Recruiting1
DB01229Paclitaxel1 / 2Completed1
DB01229Paclitaxel1 / 2Recruiting1
DB09037Pembrolizumab1 / 2Recruiting4
DB11730Ribociclib1 / 2Recruiting1
DB12893Sacituzumab govitecan1 / 2Recruiting1
DB125527-ethyl-10-hydroxycamptothecin2Completed1
DB08916Afatinib2Recruiting1
DB11595Atezolizumab2Recruiting2
DB05136Bavituximab2Withdrawn1
DB11666Buparlisib2Active Not Recruiting1
DB01101Capecitabine2Active Not Recruiting1
DB01101Capecitabine2Completed1
DB00958Carboplatin2Not Yet Recruiting1
DB00958Carboplatin2Recruiting1
DB00515Cisplatin2Recruiting1
DB00531Cyclophosphamide2Completed1
DB00531Cyclophosphamide2Not Yet Recruiting2
DB00531Cyclophosphamide2Recruiting2
DB01248Docetaxel2Not Yet Recruiting1
DB00997Doxorubicin2Completed1
DB00997Doxorubicin2Not Yet Recruiting2
DB11714Durvalumab2Recruiting1
DB12078Enobosarm2Terminated1
DB08899Enzalutamide2Recruiting1
DB00445Epirubicin2Unknown Status1
DB01590Everolimus2Recruiting1
DB12047Ganetespib2Completed1
DB00745Modafinil2Recruiting1
DB09074Olaparib2Active Not Recruiting1
DB01229Paclitaxel2Completed2
DB01229Paclitaxel2Not Yet Recruiting1
DB01229Paclitaxel2Recruiting2
DB01229Paclitaxel2Terminated1
DB01229Paclitaxel2Unknown Status1
DB01229Paclitaxel2Withdrawn1
DB09037Pembrolizumab2Recruiting3
DB11689Selumetinib2Not Yet Recruiting1
DB11800Tivozanib2Terminated1
DB00072Trastuzumab2Active Not Recruiting1
DB00515Cisplatin2 / 3Recruiting1
DB00531Cyclophosphamide2 / 3Recruiting1
DB01248Docetaxel2 / 3Recruiting1
DB00441Gemcitabine2 / 3Recruiting1
DB11595Atezolizumab3Active Not Recruiting1
DB11595Atezolizumab3Not Yet Recruiting1
DB00958Carboplatin3Active Not Recruiting1
DB00958Carboplatin3Recruiting1
DB00531Cyclophosphamide3Active Not Recruiting1
DB00997Doxorubicin3Active Not Recruiting1
DB04940Eribulin3Active Not Recruiting1
DB08871Eribulin3Active Not Recruiting1
DB00441Gemcitabine3Recruiting1
DB01229Paclitaxel3Active Not Recruiting2
DB01229Paclitaxel3Recruiting1
DB09037Pembrolizumab3Recruiting1
DB07232Veliparib3Active Not Recruiting1
DB00361Vinorelbine3Active Not Recruiting1
DB00399Zoledronic acid3Active Not Recruiting1